Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. SEAGEN INC.
EIR
•SEAGEN INC.•October 4, 2019

SEAGEN INC. – FDA EIR, Oct 4, 2019

Record Details

An FDA inspection of Seattle Genetics, Inc. was conducted from October 1-4, 2019, focusing on the company's conduct and oversight of clinical study protocol SGN22E-001 for the investigational drug enfortumab vedotin. This PDUFA BLA Sponsor inspection, guided by Compliance Program 7348.810 for Sponsors, Contract Research Organizations, and Monitors, aimed to evaluate various aspects including trial master file, site monitoring, drug safety reporting, and record keeping. While no official Form FDA 483 (Inspectional Observations) was issued, the inspection concluded with verbal discussions highlighting three key issues. Firstly, the timing and frequency of site monitoring visits at U.S. locations did not consistently align with the company's Clinical Monitoring Plan. Secondly, a non-English speaking subject, consented via a short form and translator, was not subsequently provided with a copy of the informed consent or an IRB-approved summary in their native language. Lastly, Seattle Genetics submitted IND safety report documentation late to its IND holder, Astellas, on two occasions, which in turn caused Astellas to submit Individual Case Safety Reports (ICSRs) late to the FDA. Management acknowledged these concerns, expressing an intention to evaluate and improve relevant processes, though no formal written response was required.

Company
SEAGEN INC.
Inspection date
October 4, 2019
Product type
Drugs
Office
Seattle District Office
Person
  • Mark Babbitt (Grandfather, Fisherman, and loving life!)
View Company Profile

ID · 0d015a1c-7e6d-4cca-b8fc-f6f985a9e727

Violation Codes1
21 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for SEAGEN INC.
  • 483 - 2025-05-13May 13, 2025
  • 483 - 2022-06-10June 10, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SEAGEN INC.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.